Sean McCutcheon
Stock Analyst at Raymond James
(4.40)
# 1,240
Out of 5,010 analysts
44
Total ratings
39.4%
Success rate
33.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $24 → $22 | $3.92 | +461.22% | 2 | Sep 9, 2026 | |
| XNCR Xencor | Rated: Buy | $40 → $46 | $25.00 | +84.00% | 2 | Sep 1, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $76 → $248 | $204.48 | +21.28% | 3 | Aug 27, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $11 | $1.87 | +488.24% | 3 | Aug 6, 2026 | |
| FTH Faeth Therapeutics | Initiated Coverage: Buy | $56 | $28.07 | +99.50% | 1 | Jul 31, 2026 | |
| RLAY Relay Therapeutics | Reiterated: Buy | $19 → $26 | $18.36 | +41.61% | 2 | May 19, 2026 | |
| ENGN enGene Therapeutics | Reiterated: Buy | $27 → $4 | $1.95 | +105.13% | 5 | May 8, 2026 | |
| CMPX Compass Therapeutics | Downgraded: Hold | n/a | $1.10 | - | 3 | Apr 28, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $12 → $19 | $10.65 | +78.40% | 4 | Feb 24, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $29 | $7.45 | n/a | 5 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $29.57 | n/a | 4 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $62.86 | n/a | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $750.51 | n/a | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $65 | $16.95 | n/a | 1 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 | $18.82 | n/a | 3 | Jun 13, 2025 |
BridgeBio Oncology Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $24 → $22
Current: $3.92
Upside: +461.22%
Xencor
Sep 1, 2026
Rated: Buy
Price Target: $40 → $46
Current: $25.00
Upside: +84.00%
Revolution Medicines
Aug 27, 2026
Reiterated: Buy
Price Target: $76 → $248
Current: $204.48
Upside: +21.28%
Black Diamond Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $11
Current: $1.87
Upside: +488.24%
Faeth Therapeutics
Jul 31, 2026
Initiated Coverage: Buy
Price Target: $56
Current: $28.07
Upside: +99.50%
Relay Therapeutics
May 19, 2026
Reiterated: Buy
Price Target: $19 → $26
Current: $18.36
Upside: +41.61%
enGene Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $27 → $4
Current: $1.95
Upside: +105.13%
Compass Therapeutics
Apr 28, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.10
Upside: -
Vir Biotechnology
Feb 24, 2026
Reiterated: Buy
Price Target: $12 → $19
Current: $10.65
Upside: +78.40%
REGENXBIO
Sep 5, 2025
Reiterated: Buy
Price Target: $29
Current: $7.45
Upside: n/a
Jul 24, 2025
Reiterated: Hold
Price Target: n/a
Current: $29.57
Upside: n/a
Jul 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $62.86
Upside: n/a
Jul 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $750.51
Upside: n/a
Jul 11, 2025
Initiated Coverage: Buy
Price Target: $65
Current: $16.95
Upside: n/a
Jun 13, 2025
Reiterated: Buy
Price Target: $86
Current: $18.82
Upside: n/a